Forte Biosciences

FBRX • NASDAQ • Stock Fundamentals

Forte Biosciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Paul A. Wagner, with a market cap of $356.3M.

Market Cap$356.3M

Employees11.0

CEOPaul A. Wagner

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 11, 2026 · 1 month 3 days agoQ1 2026

Next EarningsAug 13, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

FBR

Common questions about Forte Biosciences

Forte Biosciences (FBRX) has a market capitalization of $356.3M and trades on NASDAQ.

Forte Biosciences has approximately 11 employees.